Unknown PHASE3 INTERVENTIONAL 2-arm NCT01743664

The Efficacy of EMDR in Patients With PTSD in Multiple Sclerosis

The Efficacy of Eye Movement Desensitization and Reprocessing (EMDR) in Patients With Post Traumatic Stress Disorder in Multiple Sclerosis. A Randomized Controlled Trial.

Sponsor: Fondazione Italiana Sclerosi Multipla

Conditions Multiple Sclerosis Posttraumatic Stress Disorders

Interventions EMDR Relaxation

Updated 5 times since 2017 Last updated: Dec 6, 2012 Started: May 31, 2010 Primary completion: Mar 31, 2013 Completion: Feb 28, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Multiple Sclerosis and Posttraumatic Stress Disorders, this trial is ongoing. The trial is conducted by Fondazione Italiana Sclerosi Multipla and has accumulated 5 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

May 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fondazione Italiana Sclerosi Multipla
San Luigi Gonzaga Hospital

Data source: San Luigi Gonzaga Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Orbassano, Italy